12:20 PM | December 22, 2020 | Ian Young WuXi Biologics will use the acquired plant to make drug substances for COVID-19 vaccines. This information is only available to subscribers Why subscribe? chemweek.com is the one stop platform for chemical news, data and analysis across all industry sectors and geographies.